B73.00

Clinical Causes: Transmission through the bites of infected blackflies (Simulium species) that breed near fast-flowing rivers and streams. Repeated exposure to these blackflies, leading to the development of parasitic worms within the body. Infections typically occur in geographical areas such as sub-Saharan Africa, parts of Latin America, and Yemen. Unhygienic living conditions and proximity to blackfly breeding sites increase risk. Limited access to preventative measures like insect control and protective clothing can facilitate transmission.

Key Symptoms: Itching and skin rashes, especially over the abdomen, limbs, and chest. Skin changes such as hyperpigmentation and thickening. Gradual loss of vision, often starting with night blindness and followed by tunnel vision. Swelling and inflammation inside the eyes, including the cornea and uvea. Formation of cataracts in advanced stages, contributing to visual impairment. Presence of microfilariae (larval worms) in ocular tissues, detected through specialized examinations.

Diagnosis Path: Diagnosing onchocerciasis with eye involvement involves a combination of clinical evaluation and laboratory tests. Eye examinations reveal characteristic changes, such as corneal opacities and uveitis. Skin snips taken from a patient’s skin can be examined microscopically to identify microfilariae. Serological tests may detect antibodies or antigens specific to Onchocerca volvulus. In endemic regions, a history of residing near water bodies and previous blackfly bites supports the diagnosis. Advanced imaging techniques can help assess the extent of ocular damage.

Treatment Protocols: The primary treatment for onchocerciasis involves antiparasitic medications, especially ivermectin, which effectively reduces microfilariae levels and alleviates symptoms. In cases with significant eye damage, additional management may include corticosteroids to decrease inflammation and prevent further tissue damage. Surgical interventions could be necessary to address cataracts or other structural eye problems. Preventive measures, such as vector control and community health programs, are crucial in reducing disease transmission. Early detection and treatment are essential to prevent irreversible vision loss.